Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal Cancer
Clinical trial NCT00159432 · COMPLETED
Trial details
- NCT number
- NCT00159432
- Sponsor
- University of Southern California
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Primary completion
- 2009-06-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.